As previously announced, IMUNON plans to hold an End-of-Phase 2 meeting with the U.S. Food and Drug Administration (FDA) in person to discuss the design for a Phase 3 pivotal study of IMNN-001 in ...
Maximum 5 cases were reported from Chandarnagar community health centre followed by Aishbagh with 2 cases and one each from Redcross and ... Chief medical officer Dr NB Singh said: "People should use ...